Cellumen diagnostic, pharmacogenetics news

Cellumen spun out its personalized medicine unit into Cernostics Pathology Inc. The spinout will provide digital imaging pathology and diagnostics for personalized medicine. Cellumen CEO D. Lansing Taylor will serve as chairman of Cernostics. Michel Nederlof, formerly president of QED Imaging Inc., will be president and CTO. ...